This course discusses how examined the incidence of type 2 diabetes (T2D) among people with HIV and the risk factors associated with the development of T2D in this patient population.
This course discusses how comorbidities associated with inclusion body myositis (IBM) in an inpatient setting provide a bigger picture of IBM-related complications and show how IBM differs from other inflammatory myopathies.
This course discusses how patients with type 2 diabetes (T2D) have double the risk for heart failure (HF), compared to those without T2D, and that frailty is common in older adults with T2D.
This course discusses how a study that examined clinical practices and outcomes associated with behavioral symptoms among hospitalized patients with dementia.
This course discusses how the prevalence of enthesitis in patients with systemic lupus erythematosus (SLE) and that clinicians who treat patients with SLE should take notice of all tender and/or swollen joints to assess the presence of enthesitis.
This course discusses how the concomitant use of β-blockers and sulfonylureas increases the risk for severe hypoglycemia and how to gain aware of other medications that, when given together with sulfonylureas, increase the risk for hypoglycemia.